| Literature DB >> 32978303 |
Stavros Chrysidis1,2, Lene Terslev3, Robin Christensen4,5, Ulrich Fredberg2,6, Knud Larsen7, Tove Lorenzen6, Uffe Møller Døhn3, Andreas P Diamantopoulos8.
Abstract
OBJECTIVE: To evaluate the impact of a standardised training programme including equipment adjustment for experienced musculoskeletal ultrasonographers without previous experience in vascular ultrasound (US) on the reliability of US in the diagnosis of giant cell arteritis (GCA).Entities:
Keywords: Giant Cell Arteritis; Systemic vasculitis; Ultrasonography
Year: 2020 PMID: 32978303 PMCID: PMC7539855 DOI: 10.1136/rmdopen-2020-001337
Source DB: PubMed Journal: RMD Open ISSN: 2056-5933
Figure 1Ultrasound training programme.
Figure 2Study flow diagram.
Patient characteristics
| N | Mean | SD | |
|---|---|---|---|
| Continuous variables | |||
| Age, years | 112 | 72.5 | 7.9 |
| Symptom duration, weeks | 108 | 5.95 | 4.43 |
| Treatment duration, days | 112 | 0.91 | 1.55 |
| C reactive protein, mg/L | 112 | 69.4 | 61.5 |
| Dichotomous variables | N | No. | (%) |
| Women, no. (%) | 112 | 66 | 58.9 |
| PMR symptoms, no. (%) | 112 | 49 | 43.7 |
| Newly occurred localised headaches, no. (%) | 112 | 93 | 83 |
| US positive for GCA*, no. (%) | 112 | 66 | 58.9 |
| US positive for cGCA*, no. (%) | 112 | 59 | 52.6 |
| US positive for LV-GCA*, no. (%) | 112 | 21 | 18.7 |
| Halo sign TA*, no. (%) | 112 | 57 | 50.8 |
| Compression sign TA*, no. (%) | 107 | 51 | 47.6 |
| Halo sign FA*, no. (%) | 112 | 23 | 20.5 |
| Compression sign FA*, no. (%) | 107 | 17 | 15.8 |
| Halo sign AA*, no. (%) | 112 | 20 | 17.8 |
| Halo sign CA*, no. (%) | 112 | 6 | 4.4 |
*Assessed by the ‘gold standard’ assessor (APD).
AA, axillary artery; CA, common carotid artery; cGCA, cranial GCA; FA, facial artery; GCA, giant cell arteritis; LV-GCA, large vessel GCA; PMR, polymyalgia; TA, temporal artery; US, ultrasound.
Overall inter-rater reliability and agreement
| Variables | Total | Agreement | Interobserver agreement* (%) | Interobserver reliability*, kappa coefficient | 95% confidence limits |
|---|---|---|---|---|---|
|
| |||||
| US positive for GCA | 112 | No-No=43 | 96% | 0.92 | 0.85–0.99 |
|
| |||||
| US positive for cGCA | 112 | No-No=49 | 95% | 0.89 | 0.81–0.98 |
| US positive for LV-GCA | 112 | No-No=88 | 96% | 0.89 | 0.78–0.99 |
|
| |||||
| Halo sign temporal arteries, all segments | 112 | No-No=52 | 96% | 0.91 | 0.83–0.99 |
| Compression sign temporal arteries, all segments | 107 | No-No=52 | 94% | 0.89 | 0.80–0.98 |
| Halo sign facial arteries, all segments | 112 | No-No=86 | 96% | 0.87 | 0.75–0.98 |
| Compression sign facial arteries, all segments | 107 | No-No=88 | 96% | 0.86 | 0.73–0.99 |
| Hallo sign axillary arteries | 112 | No-No=90 | 97% | 0.91 | 0.81–1.00 |
| Hallo sign common carotid artery | 112 | No-No=106 | 100% | 1.00 | 1.00–1.00 |
*Between the US expert and the ultrasonographer.
cGCA, cranial GCA; GCA, giant cell arteritis; LV-GCA, large vessel GCA; US, ultrasound.